Hong‐Tao Xu

2.6k total citations
125 papers, 1.9k citations indexed

About

Hong‐Tao Xu is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hong‐Tao Xu has authored 125 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Molecular Biology, 32 papers in Oncology and 22 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hong‐Tao Xu's work include Cancer-related gene regulation (36 papers), Wnt/β-catenin signaling in development and cancer (35 papers) and RNA modifications and cancer (13 papers). Hong‐Tao Xu is often cited by papers focused on Cancer-related gene regulation (36 papers), Wnt/β-catenin signaling in development and cancer (35 papers) and RNA modifications and cancer (13 papers). Hong‐Tao Xu collaborates with scholars based in China, United States and Sweden. Hong‐Tao Xu's co-authors include Enhua Wang, Liangru Fei, Qingchang Li, Yuan Miao, Yang Liu, Liang Wang, Lian‐He Yang, Shun‐Dong Dai, Juan‐Han Yu and Xiupeng Zhang and has published in prestigious journals such as Nature Communications, PLoS ONE and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Hong‐Tao Xu

118 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hong‐Tao Xu China 26 1.2k 421 384 336 210 125 1.9k
Cristina Colarossi Italy 26 1.1k 0.9× 461 1.1× 604 1.6× 374 1.1× 190 0.9× 80 2.3k
Sara Lovisa Italy 13 920 0.8× 304 0.7× 371 1.0× 285 0.8× 130 0.6× 19 1.8k
Susan C. Hubchak United States 19 1.0k 0.8× 390 0.9× 218 0.6× 170 0.5× 98 0.5× 30 1.8k
Xiao Zhou China 26 1.1k 0.9× 531 1.3× 189 0.5× 126 0.4× 227 1.1× 94 2.6k
Niranjan Awasthi United States 25 889 0.7× 338 0.8× 703 1.8× 294 0.9× 111 0.5× 65 1.9k
Serk In Park United States 27 1.2k 1.0× 472 1.1× 1.1k 2.9× 429 1.3× 139 0.7× 57 2.3k
Zuzana Saidak France 21 1.2k 0.9× 685 1.6× 450 1.2× 793 2.4× 105 0.5× 51 2.3k
Jianye Cai China 23 975 0.8× 569 1.4× 388 1.0× 175 0.5× 364 1.7× 39 1.9k
Lixin Liu China 19 690 0.6× 337 0.8× 233 0.6× 158 0.5× 161 0.8× 59 1.3k
Bryan D. Maliken United States 14 922 0.8× 187 0.4× 260 0.7× 172 0.5× 351 1.7× 20 1.9k

Countries citing papers authored by Hong‐Tao Xu

Since Specialization
Citations

This map shows the geographic impact of Hong‐Tao Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hong‐Tao Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hong‐Tao Xu more than expected).

Fields of papers citing papers by Hong‐Tao Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hong‐Tao Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hong‐Tao Xu. The network helps show where Hong‐Tao Xu may publish in the future.

Co-authorship network of co-authors of Hong‐Tao Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Hong‐Tao Xu. A scholar is included among the top collaborators of Hong‐Tao Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hong‐Tao Xu. Hong‐Tao Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zheng, Yiwen, Mengxiao Wang, Xuewen Liu, et al.. (2025). Comprehensive identification of NRG1 fusions in 25,203 patients with solid tumors. npj Precision Oncology. 9(1). 262–262. 1 indexed citations
2.
Han, Jing, Jianhua Zhang, Yifan Hou, et al.. (2025). Regulatory effect of Wnt signaling on mitochondria in cancer: from mechanism to therapy. APOPTOSIS. 30(5-6). 1235–1252.
3.
Li, Yingchun, et al.. (2023). Endometrioid adenofibroma of ovary: A case report and review of literature. Medicine. 102(8). e32965–e32965. 1 indexed citations
4.
Wang, Minghao, Hong‐Tao Xu, Qiang Han, & Liang Wang. (2023). Significance of YAP1–MAML2 rearrangement and GTF2I mutation in the diagnosis and differential diagnosis of metaplastic thymoma. Annals of Medicine. 55(2). 2237040–2237040. 3 indexed citations
5.
Li, Jun, et al.. (2023). Incontinentia Pigmenti: A Case Report of Early Clinical Symptoms in a Lack of Family Inheritance Positive Result. Clinical Cosmetic and Investigational Dermatology. Volume 16. 1209–1214.
6.
Zhao, Huanyu, Yingchun Li, Hong‐Tao Xu, et al.. (2023). Atypical thymic carcinoid tumor with ectopic ACTH syndrome in a 33-year-old male patient: A rare case report and literature review. Medicine. 102(22). e33847–e33847.
7.
Xu, Hong‐Tao, et al.. (2019). Using 3‐dimensional ultrasound islice technology for the diagnosis of developmental dysplasia of the hip. Journal of Ultrasound in Medicine. 39(6). 1117–1123. 2 indexed citations
8.
Zhang, Wanlin, Shuang Ma, Rachel Jug, et al.. (2018). Primary testicular natural killer/T-cell lymphoma. Medicine. 97(12). e0181–e0181. 3 indexed citations
9.
Ma, Shuang, et al.. (2018). X-ray irradiation induced Disabled-2 gene promoter de-methylation enhances radiosensitivity of non-small-cell lung carcinoma cells. Journal of Experimental & Clinical Cancer Research. 37(1). 315–315. 8 indexed citations
10.
Yang, Xiaodong, Hong‐Tao Xu, Xiaohui Xu, et al.. (2015). Knockdown of long non-coding RNA HOTAIR inhibits proliferation and invasiveness and improves radiosensitivity in colorectal cancer. Oncology Reports. 35(1). 479–487. 78 indexed citations
11.
Xu, Hong‐Tao, Yang Liu, Shuli Liu, et al.. (2013). TC-1 (C8orf4) expression is correlated with differentiation in ovarian carcinomas and might distinguish metastatic ovarian from metastatic colorectal carcinomas. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 462(3). 281–287. 12 indexed citations
12.
Xu, Hong‐Tao, Qingchang Li, Shuli Liu, et al.. (2012). Atonal homolog 1 expression in lung cancer correlates with inhibitors of the Wnt pathway as well as the differentiation and primary tumor stage. Apmis. 121(2). 111–119. 7 indexed citations
13.
Yu, Juan‐Han, Yuan Miao, Hong‐Tao Xu, et al.. (2012). N-Terminal 1–54 Amino Acid Sequence and Armadillo Repeat Domain Are Indispensable for P120-Catenin Isoform 1A in Regulating E-Cadherin. PLoS ONE. 7(5). e37008–e37008. 6 indexed citations
14.
Li, Qingchang, Hui Gao, Hong‐Tao Xu, et al.. (2012). Expression of ezrin correlates with malignant phenotype of lung cancer, and in vitro knockdown of ezrin reverses the aggressive biological behavior of lung cancer cells. Tumor Biology. 33(5). 1493–1504. 46 indexed citations
15.
Wang, Yong, Yong Wang, Bo Qiu, et al.. (2011). Multifocal Intraparenchymal Langerhans’ Cell Histiocytosis Concomitant With an Arachnoid Cyst in a Child. Journal of Child Neurology. 27(6). 767–778. 2 indexed citations
17.
Miao, Yuan, Nan Liu, Yong Zhang, et al.. (2009). p120ctn isoform 1 expression significantly correlates with abnormal expression of E-cadherin and poor survival of lung cancer patients. Medical Oncology. 27(3). 880–886. 28 indexed citations
18.
Liu, Yang, Qingchang Li, Yuan Miao, et al.. (2008). Ablation of p120‐catenin enhances invasion and metastasis of human lung cancer cells. Cancer Science. 100(3). 441–448. 47 indexed citations
19.
Xu, Hong‐Tao, Lin Ma, Yang Liu, et al.. (2006). Expression of serine threonine kinase 15 is associated with poor differentiation in lung squamous cell carcinoma and adenocarcinoma. Pathology International. 56(7). 375–380. 27 indexed citations
20.
Lin, Dong, et al.. (2003). Expression of phospho-β-catenin and its significance in non-small cell lung cancer. Chinese Journal of Cancer Research. 15(1). 29–32. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026